Safety and efficacy of low-dose esterified estrogens and methyltestosterone, alone or combined, for the treatment of hot flashes in menopausal women: a randomized, double-blind, placebo-controlled study
Authors:
- Chun-Yuan GuoCGChun-Yuan Guo
- 31 January 2011
- journal article
- research article
- Published by Elsevier in Fertility and Sterility
- Vol. 95 (1) , 366-368
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Relative androgen excess during the menopausal transition predicts incident metabolic syndrome in midlife womenMenopause, 2009
- Aging of the human ovary and testisMolecular and Cellular Endocrinology, 2009
- Molecular basis for the interaction of four different classes of substrates and inhibitors with human aromataseBiochemical Pharmacology, 2008
- Effects of Conjugated Equine Estrogen in Postmenopausal Women With HysterectomyJAMA, 2004
- Comparative effects of oral esterified estrogens with and without methyltestosterone on endocrine profiles and dimensions of sexual function in postmenopausal women with hypoactive sexual desireFertility and Sterility, 2003
- Tibolone is not converted by human aromatase to 7α-methyl-17α-ethynylestradiol (7α-MEE):Steroids, 2003
- A cohort study of topical vaginal estrogen therapy in women previously treated for breast cancerClimacteric, 2003
- Risks and Benefits of Estrogen Plus Progestin in Healthy Postmenopausal Women: Principal Results From the Women's Health Initiative Randomized Controlled TrialJAMA, 2002
- 17α-Methyl testosterone is a competitive inhibitor of aromatase activity in Jar choriocarcinoma cells and macrophage-like THP-1 cells in cultureThe Journal of Steroid Biochemistry and Molecular Biology, 2001
- Comparison of oral estrogens and estrogens plus androgen on bone mineral density, menopausal symptoms, and lipid-lipoprotein profiles in surgical menopauseObstetrics & Gynecology, 1995